

Tecentriq 1200mg Injection (Atezolizumab)
Manufactured By
Roche products india pvt. ltd
Pack Of
1
Salt Composition
Atezolizumab
Storage
Keep in cold place
Fast Delivery

Easy Returns

Secure Payments

Up to 60% Discounts
Overview
Tecentriq 1200mg Injection is a prescription-based anticancer medicine used in the treatment of non-small cell lung cancer, small cell lung cancer, hepatocellular carcinoma, and melanoma. The active ingredient of the Tecentriq is Atezolizumab which belongs to the drug class of monoclonal antibodies.
This medicine works by inhibiting the activity of a protein that is found on the T-cells, which are white blood cells responsible for regulating the workings of the immune system. The effect of this medication is to increase the capability of the T-cells to kill the cancer cells.
Atezolizumab Injection is usually given in combination with another anticancer medicine as a part of combination therapy to increase the efficacy of the treatment.
Indication
Lung Cancer
Side Effects
The human body shows undesired symptoms after taking Atezolizumab 1200mg Injection (Tecentriq). Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Common Side Effects
- Some of the common side effects of Tecentriq Injection are mentioned below:
- ● Rash
- ● Fever
- ● Chills
- ● Cough
- ● Hair loss
- ● Tiredness
- ● Weight loss
- ● Muscles pain
- ● Constipation
- ● Fast heart rate
- ● Skin sensitivity
- ● Abdominal pain
- ● High blood sugar
- ● Numbness and swelling of the legs
Serious Side Effects
- ● Diabetes
- ● Skin inflammation
- ● Urinary tract infection
- ● Inflammation in brain, kidney
- ● Infection in lungs, liver, and thyroid
How To Use
Tecentriq 1200mg Injection (Atezolizumab) is a prescription-based anticancer drug. It is advised to take this injection after consulting your healthcare expert. This medicine should be given intravenously by an experienced nurse or doctor. Please do not self-administer.
Reference
● Chen, A. P., Sharon, E., O’Sullivan-Coyne, G., Moore, N., Foster, J. C., Hu, J. S., ... & Doroshow, J. H. (2023). Atezolizumab for advanced alveolar soft part sarcoma. New England Journal of Medicine, 389(10), 911-921.
● Socinski, M. A., Jotte, R. M., Cappuzzo, F., Orlandi, F., Stroyakovskiy, D., Nogami, N., ... & Reck, M. (2018). Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC. New England Journal of Medicine, 378(24), 2288-2301.
● Balar, A. V., Galsky, M. D., Rosenberg, J. E., Powles, T., Petrylak, D. P., Bellmunt, J., ... & Bajorin, D. F. (2017). Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. The Lancet, 389(10064), 67-76.
● Herbst, R. S., Giaccone, G., de Marinis, F., Reinmuth, N., Vergnenegre, A., Barrios, C. H., ... & Spigel, D. R. (2020). Atezolizumab for first-line treatment of PD-L1–selected patients with NSCLC. New England Journal of Medicine, 383(14), 1328-1339.
● Markham, A. (2016). Atezolizumab: first global approval. Drugs, 76(12), 1227-1232.
Safety Advice
- ● Alcohol: The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Tecentriq 1200mg Injection (Atezolizumab). It is advised to consult your doctor for further information.
- ● Pregnancy: Tecentriq 1200mg Injection (Atezolizumab) may be considered unsafe during pregnancy. Please consult your doctor in such condition.
- ● Breastfeeding: Atezolizumab 1200mg Injection (Tecentriq) is probably not safe if you're breastfeeding. Kindly consult your doctor.
- ● Driving: It is advisable not to drive or operate heavy machinery as you may feel dizzy after taking Tecentriq 1200mg Injection (Atezolizumab).
- ● Kidney: Share your medical history with your healthcare expert in case of kidney disease before taking Atezolizumab 1200mg Injection (Tecentriq).
- ● Liver: Inform your doctor before starting Tecentriq 1200mg Injection (Atezolizumab) if you have liver disease to avoid any serious side effects.
FAQs
What type of cancer is treated using Atezolizumab 1200mg Injection (Tecentriq)?
Atezolizumab 1200mg Injection is an prescription based anticancer medicine used to treat non-small cell lung cancer, small cell lung cancer, hepatocellular carcinoma, and melanoma.
Who are not allowed to take Tecentriq 1200mg Injection (Atezolizumab)?
This drug is not considered safe in patients who have autoimmune diseases, such as rheumatoid arthritis, or multiple sclerosis. They can get severe side effects after taking Tecentriq 1200mg injection.
Can Tecentriq 1200mg Injection (Atezolizumab) works as combination drug?
Yes, Tecentriq 1200mg Injection is used as combination drug to boost the immunity to stop the growth of cancer cells.
How will Atezolizumab 1200mg Injection (Tecentriq) given to cancer patients?
Atezolizumab 1200mg Injection should be given intravenously by an experienced nurse or doctor. Please do not self-administer.
What precautions should I take during treatment of Tecentriq 1200mg Injection (Atezolizumab)?
Avoid exposure to sun and infections, report if observe any unusual symptoms, and share your medical history with your healthcare expert, especially if you have autoimmune conditions, pregnant, planning to be pregnant, or breastfeeding.
Marketer Details
Roche products india pvt. ltd
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.


